Humana And Mark Cuban's Cost Plus Drugs Working On Partnership To Lower Prices [Forbes]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Forbes
Humana chief executive officer Jim Rechtin and Cuban, the billionaire entrepreneur who co-founded Cost Plus Drugs, disclosed the potential for such a partnership Thursday at the annual Forbes Healthcare Summit. The two, who were on the same panel, said they were working together on ways to improve patient experience at the pharmacy. The initial effort for Humana and Cost Plus Drugs will be in the area of direct-to-employer programs that bypass traditional pharmacy benefit management companies, Cuban said. “We're talking to CenterWell,” Cuban said of Humana's CenterWell healthcare services business, which includes a specialty pharmacy. “I would say we are treating the whole person plus their wallet.” Such a deal could be a big win for Cost Plus Drugs given Humana has more than 8 million health plan enrollees. Of those, more than 5 million are enrolled in Humana's Medicare Advantage plans, which are popular choices for coverage among adults who are 65 years of age and older. “The
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Continues Major International Expansion With Official Entry Into Canada [Yahoo! Finance]Yahoo! Finance
- A New Market, A New Catalyst: Assessing Hims & Hers' Canadian Opportunity [Seeking Alpha]Seeking Alpha
- Hims & Hers Health, Inc. (HIMS): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- The Three Moves Hims & Hers Made This Week To Bolster Its Weight-Loss Biz [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health signs agreement to acquire YourBio Health [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 11/3/25 - Miss
HIMS
Sec Filings
- 12/2/25 - Form 4
- 12/2/25 - Form 4
- 11/25/25 - Form 4
- HIMS's page on the SEC website